SLC6A14 and breast neoplasm: In particular, exploring the TCGA data, we show that SLC6A14 expression is highest in the basal-like subtype, which typically gives rise to the triple negative breast cancers (TNBC), the most aggressive type of breast tumors with no effective treatment strategies.